EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY-NC-ND 4.0

Burden of osteoarthritis in the Netherlands: a scoping review

Charlotte Beaudart, Nannan Li, Annelies Boonen, Mickael Hiligsmann

Expert Review of Pharmacoeconomics & Outcomes Research · 26.11.2023 · 23 (10) · 1147-1167

DOI: 10.1080/14737167.2023.2260562 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Expert Review of Pharmacoeconomics & Outcomes Research, online erschienen am 02.10.2023. Verfasst von Charlotte Beaudart und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Services Research, CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands. Hauptthemen laut MEDLINE: Osteoarthritis, Knee, Osteoarthritis, Hip. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: ReumaNederland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To provide an overview of societal burden of osteoarthritis (OA) in the Netherlands. METHODS: Medline (via Ovid) and Embase databases were searched in September 2022 for all publications providing prevalence/incidence, cost or health-related quality of life (HRQoL) data of OA (all sites) in the Netherlands. RESULTS: Twenty-eight original studies were included in this scoping review; twelve reporting prevalence/incidence data of OA, seven reporting data on the economic burden of OA and twelve reporting HRQoL data of patients with OA. Most of the available data were from Dutch national cohorts. The prevalence of knee OA ranged from 6% to 18% across studies, from 4% to 7% for hip OA and from 12% to 56% for hand OA. OA was shown to be associated with impairment in work participation and long-term requirement of health care utilization, translating into substantial medical costs and societal costs of lost productivity. All studies comparing HRQoL among persons with OA with control persons showed a significantly lower HRQoL in patients with OA after adjustment for age, sex, and various risk factors. CONCLUSIONS: OA is a highly prevalent disease in the Dutch population and is responsible for a significant economic and health burden.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Osteoarthritis, KneeOsteoarthritis, HipHumansQuality of LifeCost of IllnessNetherlands

Stichwörter der Autor:innen

Osteoarthritiseconomic burdenhealth-related quality of lifeincidenceprevalencethe Netherlands

Autor:innen und Institutionen

  • Department of Health Services Research, CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands.
  • Research Institute for Life Sciences (NARILIS), Department of Biomedical Sciences, Faculty of Medicine, University of Namur, Namur, Belgium.
  • Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, The Netherlands.

Förderung

  • ReumaNederland

Zitieren

APA

Beaudart, C., Li, N., Boonen, A., & Hiligsmann, M. (2023). Burden of osteoarthritis in the Netherlands: a scoping review. Expert Review of Pharmacoeconomics & Outcomes Research, 23(10), 1147-1167. https://doi.org/10.1080/14737167.2023.2260562

Vancouver

Beaudart C, Li N, Boonen A, Hiligsmann M. Burden of osteoarthritis in the Netherlands: a scoping review. Expert Review of Pharmacoeconomics & Outcomes Research. 2023;23(10):1147-1167. doi:10.1080/14737167.2023.2260562

BibTeX
@article{Beaudart2023,
  author = {Beaudart, Charlotte and Li, Nannan and Boonen, Annelies and Hiligsmann, Mickael},
  title = {Burden of osteoarthritis in the Netherlands: a scoping review},
  journal = {Expert Review of Pharmacoeconomics & Outcomes Research},
  year = {2023},
  volume = {23},
  number = {10},
  pages = {1147--1167},
  doi = {10.1080/14737167.2023.2260562}
}
Kostenlos starten →